A look at the history of Vertex Pharmaceuticals
Paul Daruwala, 42, left Merck & Co., a competitor in the hepatitis C drug market, last year to go work at Vertex as the vice president of marketing. Daruwala was attracted to the company because of its dedication to finding breakthrough drugs and marketing telaprevir, which Daruwala calls a "cocktail" drug you can take with other drugs.
"All the chips are on the table," Daruwala said. "Everyone is all in. You don't see that at other companies. The passions are palpable."